Robin M. Jackman
Keine laufenden Positionen mehr
Profil
Robin M.
Jackman founded January Therapeutics, Inc., where he worked as Director, Chief Operating & Financial Officer.
Dr. Jackman also formerly worked at Zacharon Pharmaceuticals, Inc., as President & Chief Executive Officer from 2009 to 2010, Orphagen Pharmaceuticals, as Director, Protein Design Labs, Inc., as Research Associate, Vical, Inc., as Senior Vice President-Business Operations, Sequenom, Inc., as Vice President-Corporate Development, and Robertson Stephens, Inc., as VP-Life Sciences Investment Banking Group from 1998 to 2002.
Dr. Jackman received his graduate degree and doctorate degree from Harvard University and undergraduate degree from Stanford University.
Ehemalige bekannte Positionen von Robin M. Jackman
Unternehmen | Position | Ende |
---|---|---|
Robertson Stephens, Inc. | Corporate Officer/Principal | 01.01.2002 |
January Therapeutics, Inc.
January Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services January Therapeutics, Inc. provides biotechnology services. The company was founded by Robin Jackman and Neil Raheja and is headquartered in San Diego, CA. | Vorstandsvorsitzender | - |
Orphagen Pharmaceuticals
Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Zacharon Pharmaceuticals, Inc.
Zacharon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Zacharon Pharmaceuticals, Inc. developed small molecular drugs. The company was founded by Jeffrey D. Esko, Charles A. Glass and Brett E. Crawford in 2004 and was headquartered in Novato, CA. | Vorstandsvorsitzender | - |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Corporate Officer/Principal | - |
Ausbildung von Robin M. Jackman
Harvard University | Doctorate Degree |
Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Sequenom, Inc.
Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Robertson Stephens, Inc. | Finance |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
Zacharon Pharmaceuticals, Inc.
Zacharon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Zacharon Pharmaceuticals, Inc. developed small molecular drugs. The company was founded by Jeffrey D. Esko, Charles A. Glass and Brett E. Crawford in 2004 and was headquartered in Novato, CA. | Health Technology |
Orphagen Pharmaceuticals
Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Health Technology |
January Therapeutics, Inc.
January Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services January Therapeutics, Inc. provides biotechnology services. The company was founded by Robin Jackman and Neil Raheja and is headquartered in San Diego, CA. | Commercial Services |